MicroED Structures of Fluticasone Furoate and Fluticasone Propionate Provide New Insights into Their Function

被引:0
|
作者
Lin, Jieye [1 ]
Unge, Johan [2 ]
Gonen, Tamir [1 ]
机构
[1] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA
[2] Umea Univ, Dept Chem, Umea 90178, Sweden
基金
美国国家卫生研究院;
关键词
GLUCOCORTICOID-RECEPTOR; LIGAND-BINDING; TRANSLOCATION; PERFORMANCE; ENERGIES; INHALER; ATOMS; SET;
D O I
10.1021/acs.cgd.4c01683
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The detailed understanding of the conformational pathway of fluticasone, a widely prescribed medicine for allergic rhinitis, asthma, and chronic obstructive pulmonary disease (COPD), from formulation to its protein-bound state, has been limited due to a lack of access to its high-resolution structures. The three-dimensional (3D) structure of fluticasone furoate 1 remains unpublished, and the deposited structure of fluticasone propionate 2 could be further refined due to refinement against new data. We applied microcrystal electron diffraction (MicroED) to determine the 3D structures of 1 and 2 in their solid states. The preferred geometries in solution were predicted by using density functional theory (DFT) calculations. A comparative analysis of the structures of 1 and 2 across three states (in solid state, in solution, and protein-bound conformation) revealed the course of the conformational changes during the entire transition. Potential energy plots were calculated for the most dynamic bonds, uncovering their rotational barriers. This study underscores the combined use of MicroED and DFT calculations to provide a comprehensive understanding of conformational and energy changes during drug administration. The quantitative comparison also highlights the subtle structural differences that may lead to significant changes in the pharmaceutical properties.
引用
收藏
页码:1588 / 1596
页数:9
相关论文
共 50 条
  • [41] Fluticasone propionate and mometasone furoate are equally effective in restoring epithelial barrier defects in allergic rhinitis
    Doulaptsi, M.
    Steelant, B.
    Seys, S.
    Prokopakis, E.
    Hellings, P.
    ALLERGY, 2017, 72 : 787 - 787
  • [42] A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD
    Agusti, Alvar
    de Teresa, Luis
    De Backer, Wilfried
    Zvarich, Michael T.
    Locantore, Nicholas
    Barnes, Neil
    Bourbeau, Jean
    Crim, Courtney
    EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (03) : 763 - 772
  • [43] Once-daily fluticasone furoate/vilanterol versus twice-daily fluticasone propionate/salmeterol in patients with asthma well controlled on ICS/LABA
    Bernstein, David
    Andersen, Leslie
    Forth, Richard
    Jacques, Loretta
    Yates, Louisa
    JOURNAL OF ASTHMA, 2018, 55 (09) : 984 - 993
  • [44] Fluticasone Furoate, a Novel Enhanced-affinity Inhaled Corticosteroid, has a Longer Duration of Anti-inflammatory Action than Fluticasone Propionate and Budesonide
    Rossios, C.
    To, Y.
    Barnes, P. J.
    Adcock, I. M.
    Johnson, M.
    Ito, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [45] A comparison of the efficacy of once-daily fluticasone furoate/vilanterole with twice-daily fluticasone propionate/salmeterol in asthma-COPD overlap syndrome
    Ishiura, Yoshihisa
    Fujimura, Masaki
    Shiba, Yasutaka
    Ohkura, Noriyuki
    Hara, Johsuke
    Kasahara, Kazuo
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 35 : 28 - 33
  • [46] SOME BIOLOGICAL-ACTIVITIES OF A NEW CORTICOSTEROID, FLUTICASONE PROPIONATE
    ENGLISH, AF
    NEATE, MS
    QUINT, DJ
    SAREEN, M
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U83 - U83
  • [47] Pharmaceutical properties of fluticasone propionate nasal drops: a new formulation
    Denyer, S
    ALLERGY, 1999, 54 : 17 - 20
  • [48] Adherence and Asthma Control with Mometasone Furoate versus Fluticasone Propionate in Adolescents and Young Adults with Mild Asthma
    Friedman, Howard S.
    Navaratnam, Prakash
    McLaughlin, John
    JOURNAL OF ASTHMA, 2010, 47 (09) : 994 - 1000
  • [49] Comparative trial of mometasone furoate versus fluticasone propionate in patients with moderate to severe persistent asthma.
    Sussman, G.
    Harnest, U.
    Price, D.
    Howes, T.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2007, 98 (01) : A59 - A59
  • [50] A pharmacokinetic/pharmacodynamic evaluation of fluticasone propionate and mometasone furoate using adrenal suppression as a surrogate marker.
    Tayab, ZR
    Fardon, T
    Lee, D
    Haggart, K
    McFarlane, L
    Lipworth, BJ
    Hochhaus, G
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1072 - 1072